ArticleApoptosis : an international journal on programmed cell death2025

Targeted editing of CCL5 with CRISPR-Cas9 nanoparticles enhances breast cancer immunotherapy.

Wei Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.